The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes with COVID-19 in patients with hematopoietic stem cell transplant and cellular therapy: A systemic review and meta-analysis.
 
Sibgha Gull Chaudhary
No Relationships to Disclose
 
Muhammad Usman Zafar
Stock and Other Ownership Interests - TherapeuticsMD
 
Maha Awaiz Hassan
No Relationships to Disclose
 
Moazzam Shahzad
No Relationships to Disclose
 
Ali Hussain
No Relationships to Disclose
 
Fatima Ali
No Relationships to Disclose
 
Yumna Riaz
No Relationships to Disclose
 
Fatima Khalid
No Relationships to Disclose
 
Sharad Khurana
No Relationships to Disclose
 
Ramesh Balusu
No Relationships to Disclose
 
Nausheen Ahmed
No Relationships to Disclose
 
Anurag K Singh
No Relationships to Disclose
 
Faiz Anwer
Honoraria - Incyte; Seagen; Seagen
Consulting or Advisory Role - Incyte; Seagen
Speakers' Bureau - Incyte
Research Funding - Abbvie; Acetylon Pharmaceuticals; Astellas Pharma; Celgene; Millennium
Travel, Accommodations, Expenses - Incyte; Seagen
 
Sunil H. Abhyankar
Consulting or Advisory Role - Incyte
Speakers' Bureau - Therakos
Research Funding - Incyte
 
Joseph McGuirk
Honoraria - AlloVir; Juno Therapeutics; Kite, a Gilead company; Magenta Therapeutics
Consulting or Advisory Role - Allovir; EcoR1 Capital; Juno Therapeutics; Kite, a Gilead company; Magenta Therapeutics
Speakers' Bureau - Kite/Gilead
Research Funding - AlloVir (Inst); Astellas Pharma (Inst); Bellicum Pharmaceuticals (Inst); Fresenius Biotech (Inst); Gamida Cell (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Novartis (Inst); Pluristem Therapeutics (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Muhammad Umair Mushtaq
No Relationships to Disclose